MOLECULAR DIAGNOSIS OF CONGENITAL ADRENAL HYPERPLASIA--PHENOTYPE/GENOTPE
MOLECULAR DIAGNOSIS OF CONGENITAL ADRENAL HYPERPLASIA--PHENOTYPE/GENOTPE
批准号:
6276740
负责人:
SELMA FELDMAN WITCHEL
金额:
$1.51万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 1998-11-30
中文摘要
利用先天性肾上腺皮质增生症,先天缺陷
类固醇合成,以提高对类固醇激素的病理生理学的认识
与高雄激素症相关的疾病。次要目标更好
了解下丘脑-垂体-肾上腺轴的功能。
临床特征、激素(生化)表型和
基因分型。从这项研究中获得的信息将有助于开发
儿童先天性肾上腺皮质增生症的最佳治疗
区分哪些患有轻度高雄激素症的儿童需要治疗
使用糖皮质激素和/或盐皮质激素药物。在.工作
进展表明21-羟基酶缺乏症具有杂合子优势。
检验这一假说的研究正在进行中。
英文摘要
To utilize the congenital adrenal hyperplasia, inborn errors of
steroidogenesis, to improve knowledge regarding the pathophysiology of
disorders associated with hyperandrogenism. A secondary goal is better
understanding of how the hypothalamic-pituitary-adrenal axis functions.
Correlation of clinical features, hormonal (Biochemical) phenotype, and
genotype. The information obtained from this study will help develop
optimal treatment for children with congenital adrenal hyperplasia and
differentiate which children with mild hyperandrogenism require treatment
with glucocorticoid and/or mineralocorticoid medications. Work in
progress suggests a heterozygote advantage for 21-hydroxylase deficiency.
Studies are being developed to test this hypothesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STUDIES OF ABNORMAL SEXUAL DIFFERENTIATION AND DEVELOPMENT:SERUM INHIBIN B & FSH
-
批准号:7203087
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2005
-
负责人:SELMA FELDMAN WITCHEL
-
依托单位:
STEROIDOGENESIS IN HYPERANDROGENISM
-
批准号:7203091
-
项目类别:
-
资助金额:$1.46万
-
财政年份:2005
-
负责人:SELMA FELDMAN WITCHEL
-
依托单位:
EVALUATION & TREATMENT OF ABNORMALITIES OF GONADAL OR PUBERTAL DEVELOPMENT
-
批准号:7203089
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2005
-
负责人:SELMA FELDMAN WITCHEL
-
依托单位:
MOLECULAR DIAGNOSIS OF CONGENITAL ADRENAL HYPERPLASIA: PHENOTYPE/GENOTYPE
-
批准号:7203088
-
项目类别:
-
资助金额:$0.82万
-
财政年份:2005
-
负责人:SELMA FELDMAN WITCHEL
-
依托单位:
Steroidogenesis in Hyperandrogenism
-
批准号:7041280
-
项目类别:
-
资助金额:$1.55万
-
财政年份:2003
-
负责人:SELMA FELDMAN WITCHEL
-
依托单位:
Studies of Abnormal Sexual Differentiation and Development:Serum Inhibin B & FSH
-
批准号:7041276
-
项目类别:
-
资助金额:$0.02万
-
财政年份:2003
-
负责人:SELMA FELDMAN WITCHEL
-
依托单位:
Evaluation & Treatment of Abnormalities of Gonadal or Pubertal Development
-
批准号:7041278
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2003
-
负责人:SELMA FELDMAN WITCHEL
-
依托单位:
Molecular Diagnosis of Congenital Adrenal Hyperplasia: Phenotype/Genotype
-
批准号:7041277
-
项目类别:
-
资助金额:$0.49万
-
财政年份:2003
-
负责人:SELMA FELDMAN WITCHEL
-
依托单位:
MOLECULAR DIAGNOSIS OF CONGENITAL ADRENAL HYPERPLASIA--PHENOTYPE/GENOTPE
-
批准号:6115506
-
项目类别:
-
资助金额:$2.06万
-
财政年份:1998
-
负责人:SELMA FELDMAN WITCHEL
-
依托单位:
STEROIDOGENESIS IN HYPERANDROGENISM
-
批准号:6115516
-
项目类别:
-
资助金额:$2.06万
-
财政年份:1998
-
负责人:SELMA FELDMAN WITCHEL
-
依托单位:
CHRONIC ANOVULATORY HYPERANDROGENISM: SORTING GENOTYPES
-
批准号:2674039
-
项目类别:
-
资助金额:$9.8万
-
财政年份:1997
-
负责人:SELMA FELDMAN WITCHEL
-
依托单位:
CHRONIC ANOVULATORY HYPERANDROGENISM: SORTING GENOTYPES
-
批准号:2399007
-
项目类别:
-
资助金额:$9.8万
-
财政年份:1997
-
负责人:SELMA FELDMAN WITCHEL
-
依托单位:
CHRONIC ANOVULATORY HYPERANDROGENISM: SORTING GENOTYPES
-
批准号:6182533
-
项目类别:
-
资助金额:$9.8万
-
财政年份:1997
-
负责人:SELMA FELDMAN WITCHEL
-
依托单位:
STEROIDOGENESIS IN HYPERANDROGENISM
-
批准号:6276750
-
项目类别:
-
资助金额:$1.51万
-
财政年份:1997
-
负责人:SELMA FELDMAN WITCHEL
-
依托单位:
CHRONIC ANOVULATORY HYPERANDROGENISM: SORTING GENOTYPES
-
批准号:6387832
-
项目类别:
-
资助金额:$9.8万
-
财政年份:1997
-
负责人:SELMA FELDMAN WITCHEL
-
依托单位:
CHRONIC ANOVULATORY HYPERANDROGENISM: SORTING GENOTYPES
-
批准号:2889329
-
项目类别:
-
资助金额:$9.8万
-
财政年份:1997
-
负责人:SELMA FELDMAN WITCHEL
-
依托单位:
STEROIDOGENESIS IN HYPERANDROGENISM
-
批准号:6246643
-
项目类别:
-
资助金额:$1.91万
-
财政年份:1996
-
负责人:SELMA FELDMAN WITCHEL
-
依托单位:
21 HYDROXYLASE DEFICIENCY CONGENITAL ADRENAL HYPERPLASIA
-
批准号:6246628
-
项目类别:
-
资助金额:$1.91万
-
财政年份:1996
-
负责人:SELMA FELDMAN WITCHEL
-
依托单位:
GENE MUTATION IN 21-HYDROXYLASE DEFICIENCY
-
批准号:2194431
-
项目类别:
-
资助金额:$9.34万
-
财政年份:1992
-
负责人:SELMA FELDMAN WITCHEL
-
依托单位:
GENE MUTATION IN 21-HYDROXYLASE DEFICIENCY
-
批准号:2194432
-
项目类别:
-
资助金额:$8.79万
-
财政年份:1992
-
负责人:SELMA FELDMAN WITCHEL
-
依托单位:
海外基金